An "AND" Logic‐Gated Prodrug Micelle Locally Stimulates Anti‐Tumor Immunity

Mengqi Chen,Chunhong Wang,Xuanyu Wang,Zhiyu Tu,Zexuan Ding,Zhibo Liu

DOI: https://doi.org/10.1002/adma.202307818

IF: 29.4

2023-11-09

Advanced Materials

Abstract:Materials that can respond to multiple biomarkers simultaneously, acting as an "AND" gate, have the potential to enhance tumor‐targeting for drug delivery. In this study, an "AND" logic‐controlled release prodrug micelle is developed for co‐delivering the chemotherapeutic and the STING agonist, enabling precise combinatorial therapy. The drug release is programmed by tumor‐enriched boramino acids (BAA) in the tumor microenvironment and intracellular reactive oxygen species (ROS), resulting in enhanced tumor targeting. STING agonist is successfully encapsulated into prodrug micelles through π–π stacking and hydrophobic interactions. These AND logic‐gated prodrug micelles can achieve tumor‐targeted delivery of STING agonist, leading to significantly enhanced immune activation and antitumor efficacy in vivo. It is expected that this clinically relevant nano‐platform will provide a rational design of an effective immunotherapy combination regimen to convert immunologically "cold" tumors to immunogenic "hot" tumors, addressing the major challenges faced by immunotherapies. This article is protected by copyright. All rights reserved

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the accuracy and efficiency of tumor - targeted drug delivery while reducing side effects on healthy tissues. Specifically, the research has developed a prodrug micelle system based on "AND" logic - gated, which can respond to specific biomarkers in the tumor microenvironment (such as boron - amino - acid (BAA) and reactive oxygen species (ROS)), achieving co - delivery of chemotherapy drugs and STING agonists, thereby precisely releasing drugs at the tumor site and enhancing the anti - tumor immune response. In this way, the system aims to improve immune activation and anti - tumor effects, and transform immunologically "cold" tumors into "hot" tumors to address the main challenges faced by immunotherapy.